today announced the results of the
antimicrobial efficacy test on a prototype of G6’s proprietary graphene-based air purifier (the
“Lab Test”) conducted by a US-based microbiological laboratory of The Intertek Group plc. The
test showed that the concentration of pathogenic microorganisms present in the testing chamber
was reduced by 99.9% (“Test Results”) over the duration of the experiment.
today announced the closing of the previously announced acquisition of all membership interests (the “Transaction”) of GX Technologies, LLC (“GX Technologies” or “GX”), effective August 25, 2021 (the “Closing Date”).
is pleased to announce that it has executed a definitive purchase agreement (the “Agreement”) to formalize and close the previously announced acquisition (the “Transaction”) of all membership interests of GX Technologies, LLC (“GX Technologies”). Pursuant to the terms of the Agreement, the consideration paid for the membership interests of GX Technologies is 25,000,000 common shares (the “Consideration Shares”) of G6 at a deemed price of C$0.20 per common share of the Company.
